Your session is about to expire
← Back to Search
Behavioral Intervention
Smartphone App for Suicidal Thoughts
N/A
Recruiting
Research Sponsored by Butler Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Presence of suicidal ideation and/or suicidal behavior in the past month
Between the ages of 18 and 70
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights
Study Summary
This trial is testing a new suicide prevention app called MAPS. They want to see if it's safe and effective.
Who is the study for?
This trial is for English-speaking adults aged 18-70 who own a smartphone and have experienced suicidal thoughts or behaviors in the past month. It's not suitable for individuals with severe psychotic or manic symptoms that could hinder participation.Check my eligibility
What is being tested?
The study is testing MAPS, a new personalized smartphone app designed to prevent suicide. The goal is to see if it's feasible, acceptable, safe, and how well it might work to reduce suicidal thoughts and behaviors as well as re-hospitalization.See study design
What are the potential side effects?
Since this intervention involves using a mobile application rather than medication, traditional side effects are not expected. However, there may be psychological impacts from engaging with content about suicide prevention.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have had thoughts or actions of suicide in the last month.
Select...
I am between 18 and 70 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acceptability of MAPS Intervention
Acceptability of Research (Dropout)
Acceptability of Research (Recruitment)
+4 moreSecondary outcome measures
Emergency Department Visits
Rehospitalization
Suicidal Ideation and Behavior
Trial Design
1Treatment groups
Experimental Treatment
Group I: Mobile Application to Prevent Suicide (MAPS)Experimental Treatment1 Intervention
Participants receiving MAPS will receive the Safety Planning Intervention (SPI) which will be uploaded into the smartphone app. They will be prompted four times per day to complete a brief ecological momentary assessment "check-in" inquiring about their cognitions, affect, and behavior, including suicidal thoughts and behaviors. Based on these responses, they will be provided with coping strategies from their safety plans and from a database of coping strategies created by study staff. They will also have access to emergency phone numbers, the coping strategies database, and can communicate with their study clinician through a text-like interface in the app. They will receive this intervention for one month.
Find a Location
Who is running the clinical trial?
Butler HospitalLead Sponsor
129 Previous Clinical Trials
16,408 Total Patients Enrolled
11 Trials studying Suicide
651 Patients Enrolled for Suicide
Brown UniversityOTHER
456 Previous Clinical Trials
563,071 Total Patients Enrolled
12 Trials studying Suicide
3,918 Patients Enrolled for Suicide
National Institute of Mental Health (NIMH)NIH
2,782 Previous Clinical Trials
2,689,097 Total Patients Enrolled
112 Trials studying Suicide
1,156,809 Patients Enrolled for Suicide
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had thoughts or actions of suicide in the last month.I am between 18 and 70 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Mobile Application to Prevent Suicide (MAPS)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is my enrollment possible for this scientific investigation?
"To be eligible for this trial, potential participants must have attempted suicide and lie between 18-70 years old. Approximately 10 applicants are being considered by the clinical trial team."
Answered by AI
Is this research endeavor taking on new participants?
"Clinicaltrials.gov has confirmed that this clinical trial, which went live on October 1st 2022, is not enrolling any more patients at present. Nonetheless, there are 243 other medical studies with open enrollment available currently."
Answered by AI
Is this trial open to individuals above the age of 35?
"Eligibility for this trial is extended to individuals older than 18 years and younger than 70."
Answered by AI
Share this study with friends
Copy Link
Messenger